Does CISPLATIN\CYTARABINE\ETOPOSIDE\METHYLPREDNISOLONE Cause Off label use? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Off label use have been filed in association with CISPLATIN\CYTARABINE\ETOPOSIDE\METHYLPREDNISOLONE. This represents 42.9% of all adverse event reports for CISPLATIN\CYTARABINE\ETOPOSIDE\METHYLPREDNISOLONE.
18
Reports of Off label use with CISPLATIN\CYTARABINE\ETOPOSIDE\METHYLPREDNISOLONE
42.9%
of all CISPLATIN\CYTARABINE\ETOPOSIDE\METHYLPREDNISOLONE reports
0
Deaths
13
Hospitalizations
How Dangerous Is Off label use From CISPLATIN\CYTARABINE\ETOPOSIDE\METHYLPREDNISOLONE?
Of the 18 reports, 13 (72.2%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CISPLATIN\CYTARABINE\ETOPOSIDE\METHYLPREDNISOLONE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does CISPLATIN\CYTARABINE\ETOPOSIDE\METHYLPREDNISOLONE Cause?
Disease progression (24)
Diffuse large b-cell lymphoma refractory (19)
Neoplasm progression (11)
Product use in unapproved indication (10)
Lymphoma (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)